Los Altos, CA, Septembe 17, 2026 –(PR.com)– TFives, which builds the t ust laye fo e d-to-e d complia ce i Life Scie ces, e su i g AI/Age tic deployme ts ac oss the egulato y gate, today amed Rob Me ill, JD as Chief Executive Office . Me ill steps up f om the compa y’s adviso y boa d a d joi s alo gside the close of Tfives’ Seed fi a ci g ou d.
Me ill has spe t mo e tha 25 yea s focusi g o isk ma ageme t a d complia ce i the pha maceutical, biotech ology, a d medical tech ology i dust ies. His expe tise focused o legal a d egulato y FDA Adve tisi g a d P omotio Review Complia ce, Healthca e Complia ce P og am Developme t a d FDA a d OIG E fo ceme t Remediatio . He has assisted compa ies of all sizes both i -house a d as a adviso .
The key fou datio that Me ill b i gs to the ole is the followi g:Expe t E te p ise Fou datio : Led healthca e complia ce, p omotio al eview, a d egulato y affai s g oups at compa ies like Abbott Labo ato ies, Biovail, Adolo , a d a healthca e complia ce adviso y p actice at E st & You g.
P ove Exits: Fou ded Sea chlight Complia ce Adviso s, the co-fou ded O eSou ce Regulato y & Tech ology, the fi st fi m of its ki d to leve age a tech-e abled se vices st ategy that he built i to a i dust y sta da d befo e its acquisitio by P oPha ma G oup.
Scale & Adviso y: Ra platfo m i teg atio a d expa sio as SVP at P oPha ma G oup a d has se ved as a boa d adviso to ma y AI health tech sta tups developi g a d deployi g AI tech ology solutio s i the i dust y, like A eti Health a d othe Stealth Sta tups focusi g o egulato y complia ce.
Health Tech Sta tup a d I vestme t: Fou ded a stealth health tech sta tup focused o utilizi g AI to dis upt Pha ma a d Biotech comme cializatio p oduct commu icatio s a d i vested i othe health tech ve tu es th ough Qua ius Capital Pa t e s.
“Rob has spe t 25 yea s e su i g the complia ce i f ast uctu e is meeti g the cha gi g isks as laws, egulatio s a d policies evolve, which is the exact egulato y p essu es a d challe ges AI tech ology is fo ci g ou custome s to add ess. That’s the ki d of lea i g that ca be efit e te p ises, especially whe you add the TFives Tech ology platfo m,” said P akash Si gh, Co-Fou de , a d Chief Reve ue Office of TFives.
“Biopha ma compa ies wa t to deploy AI a d a e i vesti g la ge amou ts of mo ey to use AI i p oduct developme t th ough comme cializatio . The challe ge fo the legal, egulato y a d medical expe ts is if the AI o age tic AI is acti g with i teg ity a d withi the egulato y complia ce f amewo k. Tfives has developed a o chest atio e gi e of p oof that will evolutio ize how AI is adopted a d I am excited to help the amazi g TFives team take it i to the ma ket,” said Rob Me ill, CEO of TFives.
“Scali g this ki d of platfo m i life scie ces takes eal egulato y i sti ct. Rob has lived i that wo ld fo decades, he’s built compa ies, led acquisitio s, k ows exactly what ou custome s a e up agai st i this ew wo ld. Now that we have the co e team i place, I ca co ti ue to focus o the p oduct evolutio , expa sio of the egulato y f amewo k, custome success, a d keepi g the p oduct o the cutti g edge of i ovatio ,” said Ta i i Mohapat a, Fou de a d CPTO.
The appoi tme t follows a st etch of mome tum fo TFives, i cludi g SOC 2 validatio a d a fi alist spot i the 2026 Fie ce AI I ovatio Awa ds. The Fie ce AI I ovatio Awa ds ide tify a d showcase outsta di g i ovatio that is d ivi g imp oveme t a d t a sfo mi g the i dust y.
About TFivesTogethe , we T a sfo m th ough T ust, Tech ology a d T a spa e cy. This is what TFives sta ds fo a d th ough this f amewo k we a e t a sfo mi g Pha maceutical Complia ce. TFives goal is to elimi ate egulato y f ictio ac oss the complete p oduct lifecycle – f om discove y th ough comme cializatio . TFives builds dete mi istic complia ce a d AI gove a ce i f ast uctu e fo life scie ces, givi g biopha ma teams ve ifiable, audit- eady p oof fo egulated e vi o me ts without comp omisi g complia ce. Lea mo e at www.tfives.com.
